Literature DB >> 15159656

Pro-oxidant and antioxidant factors in acute intermittent porphyria: family studies.

E Rocchi1, P Ventura, A Ronzoni, M C Rosa, C Gozzi, L Marri, G Casalgrandi, M D Cappellini.   

Abstract

Given the crucial role of iron and porphyrins in oxidative cellular damage in the chronic porphyrias, we undertook an extensive study in families with acute porphyrias to evaluate the possible role of similar oxidative damage in these diseases, whose natural history is often also complicated by neoplastic evolution. Four unrelated patients with acute intermittent porphyria (AIP) were studied together with 37 members of four different families. Aminolevulinic acid and porphobilinogen were measured in urine, and porphyrins in urine, plasma and stools. The activity of the congenitally deficient enzyme, porphobilinogen deaminase, and the concentrations of plasma iron, transferrin, ferritin, and various antioxidants (ascorbic acid, retinol, tocopherol, alpha- and beta-carotene, by a personal HPLC method) and the urinary and plasma metabolites of nitrous oxide were also assayed. The results showed no relationship between the observed increase of porphyrin metabolites and the presence of markers of oxidative damage or the decrease of circulating antioxidants: however, when such a decrease was registered, it depended on spontaneous or iatrogenic iron accumulation. We conclude that family screening, recommended for the identification of AIP carriers, must also include evaluation of iron stores with a view to preventing the oxidative damage and in order to forestall the neoplastic evolution of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15159656     DOI: 10.1023/B:BOLI.0000028795.84156.da

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  30 in total

Review 1.  Melatonin protects against oxidative stress caused by delta-aminolevulinic acid: implications for cancer reduction.

Authors:  Małgorzata Karbownik; Russel J Reiter
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

Review 2.  Porphyrins, porphyrin metabolism and porphyrias. I. Update.

Authors:  S Thunell
Journal:  Scand J Clin Lab Invest       Date:  2000-11       Impact factor: 1.713

3.  A micromethod for free erythrocyte porphyrins: the FEP test.

Authors:  S Piomelli
Journal:  J Lab Clin Med       Date:  1973-06

4.  [Quantitative determination of delta-aminolevulinic acid and porphobilinogen in urine, using ion exchange chromatography columns].

Authors:  M Doss; A Schmidt
Journal:  Z Klin Chem Klin Biochem       Date:  1971-03

5.  Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias.

Authors:  C K Lim; T J Peters
Journal:  Clin Chim Acta       Date:  1984-05-16       Impact factor: 3.786

6.  Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors.

Authors:  C Andant; H Puy; C Bogard; J Faivre; J C Soulé; Y Nordmann; J C Deybach
Journal:  J Hepatol       Date:  2000-06       Impact factor: 25.083

Review 7.  Acute intermittent porphyria.

Authors:  B Grandchamp
Journal:  Semin Liver Dis       Date:  1998       Impact factor: 6.115

8.  Melatonin prevents delta-aminolevulinic acid-induced oxidative DNA damage in the presence of Fe2+.

Authors:  W Qi; R J Reiter; D X Tan; L C Manchester; J R Calvo
Journal:  Mol Cell Biochem       Date:  2001-02       Impact factor: 3.396

Review 9.  Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases.

Authors:  Andrew J Maxwell
Journal:  Nitric Oxide       Date:  2002-03       Impact factor: 4.427

10.  Acute intermittent porphyria: heterogeneity of mutations in the hydroxymethylbilane synthase gene in Italy.

Authors:  F Martinez di Montemuros; E Di Pierro; G Biolcati; E Rocchi; E Bissolotti; D Tavazzi; G Fiorelli; M D Cappellini
Journal:  Blood Cells Mol Dis       Date:  2001 Nov-Dec       Impact factor: 3.039

View more
  3 in total

1.  The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine.

Authors:  Paolo Ventura; Maria Domenica Cappellini; Emilio Rocchi
Journal:  Intern Emerg Med       Date:  2009-05-29       Impact factor: 3.397

2.  Endothelial Dysfunction in Acute Hepatic Porphyrias.

Authors:  Andrea Ricci; Gilda Sandri; Matteo Marcacci; Elena Di Pierro; Francesca Granata; Chiara Cuoghi; Stefano Marchini; Antonello Pietrangelo; Paolo Ventura
Journal:  Diagnostics (Basel)       Date:  2022-05-24

Review 3.  Nutrients and Porphyria: An Intriguing Crosstalk.

Authors:  Elena Di Pierro; Francesca Granata
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.